CXCL8 and cystic fibrosis: The chemokine IL-8 is abundantly expressed at sites of chronic inflammation and appears to play a major role in driving the formation of neutrophil (PMN)-rich exudates in the lungs of CF patients [5]–[8]; thus its reduction is a key therapeutic goal in CF.